In its first-quarter 2026 investor letter, Madison Large Cap Fund highlighted Danaher Corporation (NYSE:DHR).
Danaher Corporation (NYSE:DHR) is a healthcare and life science tools company that operates through Biotechnology, Life Sciences, and Diagnostics segments
On June 12, 2026, Danaher Corporation (NYSE:DHR) closed at $180.10 per share. One-month return of Danaher Corporation (NYSE:DHR) was 9.78%, and its shares lost 10.55% over the past 52 weeks. Danaher Corporation (NYSE:DHR) has a market capitalization of $127.47 billion.
Madison Large Cap Fund stated the following regarding Danaher Corporation (NYSE:DHR) in its Q1 2026 investor letter: “Our two life science tools investments, Danaher Corporation (NYSE:DHR) and Agilent, round out the top five detractors. Both companies reported results broadly consistent with expectations. However, while each respective company’s outlook for 2026 calls for continued end market recovery, it was at a slower pace than investors hoped.